Additionally, lenvatinib-induced METTL1/WDR4-mediated modification of the m7G tRNA facilitates the translation of EGFR and its associated pathway, thereby ultimately eliciting drug resistance in HCC cells [155]. The gene discussed is METTL1; the disease is hepatocellular carcinoma.